Can Dynamic MR Imaging Predict Response in Patients with Rectal Cancer Undergoing Cetuximab-Based Neoadjuvant Chemoradiation?

Publisher： Karger

E-ISSN： 2296-5262|32|3|86-93

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.3, 2009-02, pp. : 86-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiation

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 6, 2015-06 ,pp. : 1646-1653

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 1054-1058

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dynamic contrast‐enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 3, 2015-09 ,pp. : 673-680

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delivery of neoadjuvant chemoradiation for patients with stage II and III rectal cancer is suboptimal

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 66, Iss. 5, 2016-09 ,pp. : 357-358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Standardized Uptake Value of FDG-PET/CT Predictive of Pathological Complete Response in Locally Advanced Rectal Cancer Treated with Capecitabine-Based Neoadjuvant Chemoradiation?

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 191-199

Karger

Access to resources Recommend Favorite